$ALT News Article - AdCOVID(TM), Altimmune's Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection
https://marketwirenews.com/news-releases/adco...75153.html